References
-
1
Brunelleschi S, Zeppegno P, Risso F, Cattaneo CI, Torre E.
Risperidone-associated hyperprolactinemia: Evaluation in twenty psychiatric outpatients.
Pharmacol Res.
2003;
48
405-409
-
2
Koch M.
On the effects of partial agonists of dopamine receptors for the treatment of schizophrenia.
Pharmacopsychiatry.
2007;
40
34-39
-
3
Lee B-H, Kim Y-K, Park S-H.
Using aripiprazole to resolve antipsychotic-induced symptomatic hyperprolactinemia: a pilot study.
Prog Neuro-Psychopharmacol Biol Psychiat.
2006;
30
714-717
-
4
Leuner K, Müller WE.
The complexity of the dopaminergic synapses and their modulation by antipsychotics.
Pharmacopsychiatry.
2006;
39
((Suppl 1))
15-20
-
5
Szarfman A, Tonning JM, Levine JG, Doraiswamy PM.
Atypical antipsychotics and pituitary tumors: A pharmacovigilance study.
Pharmacotherapy.
2006;
26
748-758
Correspondence
Dr. med. A. J. Sheldrick
Klinik für Psychiatrie und Psychotherapie
Universitätsklinikum Aachen
Pauwelsstr. 30
52074 Aachen
Germany
Telefon: +49/241/803 58 91
Fax: +49/241/808 23 97